Related Experiment Video
Updated: Jan 7, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Patient-reported substance use in heart failure
Kenneth E Freedland1, Brian C Steinmeyer1, Judith A Skala1
1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Substance use disorders are common in heart failure patients, affecting nearly half of those studied. These conditions are linked to smoking, COPD, and poor quality of life, highlighting a need for integrated care.
Area of Science:
- Cardiology
- Psychiatry
- Public Health
Background:
- Substance use disorders (SUDs) are common in heart failure (HF) patients, complicating care.
- Previous research relied on epidemiological data; this study used in-depth interviews.
- Understanding patient-reported SUDs and polysubstance use in HF is crucial.
Purpose of the Study:
- To document the prevalence of patient-reported substance use comorbidities in heart failure (HF) patients.
- To identify the extent of polysubstance use within this population.
- To explore associations between SUDs and other health factors.
Main Methods:
- 362 heart failure patients were interviewed within two weeks of hospital discharge.
- The NetSCID-5 interview assessed substance use and psychiatric disorders.
- Social determinants of health, stress, and quality of life were also measured.
Main Results:
- Alcohol (26%), stimulant (10%), and cannabis (6%) use disorders were prevalent.
- Approximately 9% of HF patients reported polysubstance use.
- SUDs correlated with smoking, COPD, adverse social determinants, and lower quality of life.
Conclusions:
- Substance use disorders are frequent comorbidities in heart failure patients.
- Integrated care approaches are necessary for managing these dual conditions.
- Further research into prevention and treatment strategies for SUDs in HF is essential.
More Related Videos
Related Concept Videos
Heart Failure VII: Nursing Interventions
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: β-Blockers
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inotropic Agents
Heart Failure III: Clinical Manifestations

